Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications.

Annals of hematology - 1 Jun 2017

Kraft Julia, Sunder-Plassmann Raute, Mannhalter Christine, Quehenberger Peter, Tews Gernot, Langer Martin, Pabinger Ingrid

Abstract excerpt

Data regarding outcome and therapy of pregnancies in patients with homozygous antithrombin (AT) deficiency are very rare. We conducted a retrospective, descriptive investigation with emphasis on the obstetric history of eight women with homozygous AT deficiency heparin-binding site (HBS), who had at least one pregnancy. The aim of the study was to get a better insight into the outcome and identify suitable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abortion, Spontaneous
Share to Antithrombin III

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heparin

Share to Live Birth

Share to Outcome Assessment, Health Care

Share to Pregnancy Complications, Hematologic

Share to Premature Birth

Share to Thrombophilia

Source

Identifiers

PMID: 28361296
DOI: 10.1007/s00277-017-2965-2

Genes

SERPINC1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications.PMID 28361296Read ↗

Management and outcome of pregnancies in women with antithrombin deficiencySemantic proximity Read ↗

Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency.Semantic proximity Read ↗

Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation.Semantic proximity Read ↗

Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.Semantic proximity Read ↗

[Prevalence of factor V Leiden, hyperhomocysteinemia, prothrombin G20210A, and methylene tetrahydrofolate reductase C677T mutations in obstetrical complications].Semantic proximity Read ↗

Atypical pulmonary thromboembolism caused by the mutation site SERPINC1 of the antithrombin III gene: A case report.Semantic proximity Read ↗

How I treat heterozygous hereditary antithrombin deficiency in pregnancy.Semantic proximity Read ↗

Inherited thrombophilia and anticoagulant therapy for women with reproductive failureSemantic proximity Read ↗

Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy.Semantic proximity Read ↗

Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.Semantic proximity Read ↗

[Antithrombin homozygous type II HBS deficiency (99Leu-Phe) associated with recurrent arterial thrombosis].Semantic proximity Read ↗

Management of Sickle Cell Disease in PregnancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.